Therapeutic Apheresis - A US Market Review

Therapeutic Apheresis - A US Market Review

Although therapeutic apheresis is a potential market, soaring treatment costs and lack of awareness debilitate its growth. However, with increasing alliances and agreements, research for new procedures and more sophisticated applications underway, apheresis technology is likely to have major market opportunities for supplies, services and equipment. Reimbursement policies of both government and private insurance companies play a major role in the increase of therapeutic application in several diseases. Emerging applications of therapeutic apheresis in Autoimmune Diseases, Refractory Chronic GvHD, Lupus Erythematosus, Hyperlipidemia, Atherosclerosis and Renal Diseases are forecast to bolster volumes of growth. The pediatric segment provides a potential opportunity to expand the therapeutic apheresis market.

These and other market data and trends are presented in "Therapeutic Apheresis: US Market Review" by BizAcumen, Inc. Our reports are designed to be most comprehensive in geographic coverage and vertical market analyses.

THERAPEUTIC APHERESIS BMR-1035


Contents


1. METHODOLOGY 1
Study Reliability and Reporting Limitations 1
Disclaimers 2
Quantitative Techniques & Reporting Level 3

2. MARKET ANALYSIS 3
A Promising Outlook 4

3. MARKET TRENDS 5
Apheresis Process Leads to Rise in Platelet Donors 5
Therapeutic Apheresis Devices - A Perplexing Market 5
Plateletpheresis: The Treatment of Choice for Patients 5
Photopheresis Market Growing at a High Rate 6
Vendors’ Attitude Hampers Growth Prospects of Therapeutic
Apheresis 6
Developing New Applications for Therapeutic Apheresis is the
Need of the Hour 7
CFA - An Effective Way to Pull Up Cold Hemagglutinin Disease 7

4. COMPETITIVE SCENARIO 8
Overview 8
Technology: The Only Key for Success 8
CaridianBCT: The World Leader 9
Market Share Trends in the Recent Past 9
By Procedures (Revenues) 9
By Procedures (Number of Procedures) 10
By Neurology Disorders (Revenues) 10
By Neurology Disorders (Number of Procedures) 11
By Hematology and Oncology Disorders (Revenues) 11
By Hematology and Oncology (Number of Procedures) 12

5. MARKET OVERVIEW & OUTLOOK 12
Market Drivers 13
New Reimbursement Policies Create Growth Opportunities for
Therapeutic Apheresis 13
Increased Industry Consolidation Drives Research 13
Development of New Technology 14
Research Unveils Novel Applications 14
Market Restraints 14
Lack of Awareness Restrains Growth 14
Therapeutic Apheresis Costs Still a Concern 14
Market Challenges 15
Development of Inexpensive Apheresis Therapy 15
Scarcity of Qualified Donors 15
Pediatry: An Untapped Opportunity 15

6. REGULATORY ENVIRONMENT 16

7. PRODUCT FACTS 17
Plasmapheresis 17
Immunoadsorption 17
Erythrocytapheresis 17
Plateletpheresis 17
Leukapheresis 17
Photopheresis 17
Lipidpheresis 18

8. PRODUCT TRENDS AND ISSUES 19
Therapeutic Plasmapheresis with Fresh Frozen Plasma (FFP)
Replacement 19
Risks Associated with Therapeutic Apheresis 20
Categories of Indications for Therapeutic Apheresis 20
Plasma Exchange and Plasmapheresis: The Difference 21
Applications of Plasma Exchange 21
Chronic Diseases 21
Acute Self-Limited Disease 21
Emerging Applications 22

9. CORPORATE DEVELOPMENTS 22
Gambro to Change Name to CaridianBCT 22
Therakos Obtains CE Mark in Europe 22
Baxter Divests Transfusion Therapies Business 23
SCSG Gets Hold of Fresenius Medical Care Extracorporeal Alliance 23
Rheologics Technologies Takes Over Cardiodyne Electronics 23
Biotest Obtains Business Unit of Nabi BioPharmaceuticals 23
Gambro BCT Receives FDA Clearance for Spectra Optia System 23
MedaSorb Receives Rights for Blood Processing 24

10. MAJOR PLAYERS 24
Baxter Healthcare Corporation 24
CaridianBCT, Inc. 24
Fenwal, Inc. 25
Fresenius Medical Care North America (FMCNA) 25
Haemonetics Corporation 25
HemaCare Corporation 26
Hospital Clinical Services Group, Inc. (HCSG) 26
Therakos, Inc 26

11. MARKET ANALYTICS 27


EXHIBITS

Table 1: Percentage Breakdown of Leading Players in the US
Market for Therapeutic Apheresis - 2005

Table 2: Percentage Breakdown of Leading Players in the US
Market for Therapeutic Apheresis - 2005

Table 3: Percentage Breakdown of Leading Players in the US
Market for Therapeutic Apheresis in Neurological Disorders -
2005

Table 4: Percentage Breakdown of Leading Players in the US
Market for Therapeutic Apheresis in Neurological Disorders -
2005

Table 5: Percentage Breakdown of Leading Players in the US
Market for Therapeutic Apheresis in Hematology and Oncology
Disorders - 2005

Table 6: Percentage Breakdown of Leading Players in the US
Market for Therapeutic Apheresis in Hematology and Oncology
Disorders - 2005

Table 7: Therapeutic Apheresis Market by Procedure in the US:
2007-2015 (Sales in US$ Thousand)

Table 8: Percentage Breakdown of Therapeutic Apheresis Market
by Procedure in the US for the Years 2008 & 2012

Table 9: Therapeutic Apheresis Market by End Use in the US:
2007-2015 (Sales in US$ Thousand)

Table 10: Percentage Breakdown of Therapeutic Apheresis Market
by End Use in the US for the Years 2008 & 2012


COMPANIES PROFILED